Hot Pursuit     17-Jan-25
Caplin Point Lab arm receives USFDA nod for seizures treatment injection
Caplin Point Laboratories has announced that its subsidiary, Caplin Steriles, has received final nod from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Levetiracetam in sodium chloride injection.
Levetiracetam in sodium chloride injection is an antiepileptic drug indicated for adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy, myoclonic seizures in adults with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy."

The said drug is a generic therapeutic equivalent of the Reference Listed Drug (RLD) from HQ Specialty Pharma Corp.

This is the second Ready-To-Use Infusion bag (RTU Bags) ANDA drug product approved for Caplin Steriles, with a further 6 products under review with FDA for RTU Bags segment.

According to IQVIATM (IMS Health), Levetiracetam in Sodium Chloride Injection had US sales of approximately $19 million for the 12-month period ending November 2024.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company’s consolidated net profit grew 14.04% to Rs 130.80 crore on 17.81% increase in revenue from operations to Rs 483.10 crore in Q2 FY25 over Q2 FY24.

The scrip slipped 1.27% to Rs 2,241 on the BSE.

Previous News
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 07-Aug-24   13:17 )
  Benchmarks trades with small gains; media shares in demand
 ( Market Commentary - Mid-Session 19-Aug-24   10:33 )
  Volumes soar at Hindustan Zinc Ltd counter
 ( Hot Pursuit - 19-Aug-24   11:00 )
  Caplin Point Laboratories announces board meeting date
 ( Corporate News - 10-May-24   11:22 )
  Caplin Point Laboratories Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Aug-24   12:00 )
  Caplin Point rallies after Q1 PAT climbs 20% YoY to Rs 125 cr
 ( Hot Pursuit - 07-Aug-24   13:23 )
  Caplin Point Labs gains after subsidiary gets US FDA nod for NSAID injection
 ( Hot Pursuit - 12-May-23   12:13 )
  Caplin Steriles receives USFDA approval for Ketorolac Tromethamine Injection
 ( Corporate News - 12-May-23   12:02 )
  Caplin Point Laboratories receives INVIMA approval for Softgel Capsules division at Puducherry
 ( Corporate News - 06-May-24   14:53 )
  Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
 ( Corporate News - 16-Apr-24   11:32 )
  Indices trade with major gains; pharma shares in demand
 ( Market Commentary - Mid-Session 07-Aug-24   14:33 )
Other Stories
  Jubilant FoodWorks drops after Q3 PAT slumps 24% YoY to Rs 496 cr
  12-Feb-25   15:57
  Reliance Industries hits 14-month low; down over 5% in four sessions
  12-Feb-25   15:51
  P&G Health gains as Q3 PAT jumps 26% YoY to Rs 91 cr; declares interim dividend of Rs 80/share
  12-Feb-25   15:45
  Campus Activewear spurts after Q3 PAT climbs 87% YoY to Rs 46 cr
  12-Feb-25   15:13
  Gensol Engineering Ltd leads losers in 'A' group
  12-Feb-25   15:00
  Pearl Global rallies after strong Q3 numbers
  12-Feb-25   14:53
  Patel Engg climbs after Q3 PAT jumps 14% YoY to Rs 80 cr
  12-Feb-25   14:52
  WPIL Ltd leads losers in 'B' group
  12-Feb-25   14:45
  Crisil Ratings assigns 'A+' rating to bank facilities of Acme Solar Holdings
  12-Feb-25   14:44
  Ashok Leyland soars after strong Q3 outcome
  12-Feb-25   14:34
Back Top